Does Mounjaro Work Better Than Ozempic? A Closer Look at Their Effectiveness and Uses

Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Two medications have dominated conversations about prescription weight loss: tirzepatide (brand name Mounjaro) and semaglutide (Ozempic, Wegovy). While both belong to the GLP-1 agonist class, tirzepatide activates a second receptor called GIP, making it a dual-action compound. Clinical trials show tirzepatide users lost slightly more weight on average than semaglutide users, but individual results vary significantly based on genetics, metabolism, and lifestyle factors.

How Tirzepatide and Semaglutide Work Differently

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that controls blood sugar and appetite. When semaglutide binds to GLP-1 receptors in the brain and gut, it slows gastric emptying, increases feelings of fullness, and reduces hunger signals. This single-pathway mechanism has proven effective for weight management and blood sugar control.

Tirzepatide activates both GLP-1 and GIP receptors simultaneously. GIP (glucose-dependent insulinotropic polypeptide) is another hormone that affects insulin secretion, energy expenditure, and appetite regulation. By targeting both pathways, tirzepatide may enhance weight loss through multiple metabolic channels. Some research suggests the dual action provides stronger appetite suppression and improved metabolic flexibility.

Weight Loss Results: Clinical Trial Evidence

In the SUSTAIN trials, semaglutide at maximum doses produced average weight losses of 15 to 17 percent of body weight over 68 weeks. These results represented a significant breakthrough for adults with obesity or type 2 diabetes. The medication demonstrated consistent efficacy across diverse patient populations and maintained benefits during extended treatment periods.

Tirzepatide trials (SURPASS series) showed average weight losses ranging from 20 to 22 percent of body weight at higher doses over similar timeframes. In head-to-head comparisons, tirzepatide users consistently achieved numerically greater weight reductions than those on semaglutide. However, individual response varies—some patients respond equally well to semaglutide, while others achieve better results with tirzepatide depending on their genetic predispositions and baseline metabolism.

Choosing Between Them: Individual Response Matters Most

The best medication for you depends on your unique biology, health history, and weight loss goals. Both medications require commitment to consistent dosing and lifestyle changes for optimal results. Genetic factors influence how your body metabolizes these compounds and how effectively you respond to GLP-1 or dual GLP-1/GIP signaling.

PlexusDx offers the Precision Peptide Genetic Test to identify your individual peptide pathway predispositions. This test examines key genetic variants including GLP1R rs6923761 and GIPR rs1800437—markers that influence how strongly you respond to each medication class. Armed with this insight, you and your provider can select the compound most likely to work synergistically with your metabolism.

Side Effects and Tolerability Profiles

Both tirzepatide and semaglutide commonly cause nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. These gastrointestinal effects typically diminish over time as your body adjusts. Serious adverse events remain rare in clinical trials when medications are used as prescribed under medical supervision.

Tirzepatide users sometimes report slightly higher rates of nausea during the initial dose-escalation phase compared to semaglutide starters. However, tolerability improves significantly once steady-state dosing is reached. Individual responses vary widely—some patients tolerate tirzepatide better, while others find semaglutide more comfortable. Your provider should monitor you closely during the first 4-8 weeks to assess side effect burden and adjust timing or dose if needed.

PlexusDx Tirzepatide Injection: Accessibility and Cost

PlexusDx compounds tirzepatide through licensed 503A pharmacies and delivers it nationwide without requiring insurance or membership fees. Compounded tirzepatide injection starts at $249 per month, with pricing that remains flat regardless of your dose level—meaning your dose may increase as your body adapts, but your monthly cost won't. This transparent pricing model removes barriers to consistent treatment.

PlexusDx also offers oral tirzepatide ($279/mo), semaglutide injection ($149/mo), oral semaglutide ($249/mo), and the innovative GLP-Squared dual-compound injection ($249/mo) for patients exploring combination peptide therapy. All medications are HSA/FSA eligible, and the optional Precision Peptide Genetic Test ($99) can guide your medication selection during your first month of treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I definitely lose more weight on tirzepatide than semaglutide?

Clinical trials show tirzepatide users lost slightly more weight on average, but individual results depend heavily on your genetics, metabolism, and adherence to treatment. Some patients respond equally well or better to semaglutide. The Precision Peptide Genetic Test helps identify which pathway your body favors, improving your chances of selecting the right medication first.

How do GLP-1 and GIP receptors influence weight loss differently?

GLP-1 receptors primarily regulate appetite, gastric emptying, and blood sugar control. GIP receptors additionally influence insulin secretion and energy expenditure. Tirzepatide's dual activation may produce synergistic effects in some patients, but semaglutide's single-pathway focus remains highly effective for many individuals, especially those with certain genetic profiles.

What does PlexusDx compounded tirzepatide cost, and does the price change with my dose?

PlexusDx tirzepatide injection starts at $249 per month and remains that price regardless of your dose level—your dose may increase, but your price won't. This flat pricing applies across all three commitment tiers. The medication is compounded by licensed 503A pharmacies, delivered nationwide, and is HSA/FSA eligible with no insurance or membership required.

Are compounded tirzepatide and semaglutide as safe as brand-name versions?

PlexusDx compounds all medications through licensed 503A pharmacies, which follow FDA sterility and potency standards. While compounded medications are not FDA-approved like Mounjaro or Ozempic, they undergo rigorous quality control. Safety depends on proper medical supervision, accurate dosing, and monitoring for side effects—all provided through PlexusDx's care model.

How can the Precision Peptide Genetic Test help me choose between tirzepatide and semaglutide?

The test examines 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and GIPR rs1800437. These markers reveal whether your genetic makeup favors strong GLP-1 signaling, dual GLP-1/GIP activation, or other peptide pathways. This $99 add-on after your first treatment month provides personalized insights that guide medication optimization.

Related Reading

• Ozempic Vs Mounjaro 2
• Mounjaro Vs Ozempic 2
• Mounjaro Uses
• Ozempic Uses

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.